CDC figures say nearly three in four US adults felt very tired some days lately. A local practice promotes peptides and NAD for energy, claims that are its own.
Recap by typeshit. Full story at Local 12 WKRC-TV.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
Trefis says investors are watching whether MariTide's vomiting rate lands in the mid-20s or lower. Amgen also dropped an early obesity drug, AMG 513.
Demócrata reports Lilly's oral GLP-1 met cardiovascular safety and lowered blood sugar and weight in type 2 diabetes. Few details beyond the headline.
Loading…